 Baltimore Sun |
Advisory Panel Backs Approval for Weight-Loss Drug
New York Times A federal advisory panel on Wednesday overwhelmingly recommended approval of what could become the first new prescription drug to treat obesity in 13 years. The advisory committee to the Food and Drug Administration voted 20 to 2 that the benefits of … FDA panel backs previously rejected obesity pill Federal Panel Approves Weight-Loss Drug Qnexa FDA Advisory Panel Gives Green Light to Qnexa Diet Pill |
 Telegraph.co.uk |
Risk of depression appears to stay elevated even if the pain stops, research finds
CNN (Health.com) — Middle-aged women are roughly 40% more likely to become depressed if they experience migraine headaches, new research suggests. What's more, their risk of depression appears to stay elevated even if the pain stops. Migraines Linked to Depression Migraine increases risk of depression Migraines Linked to Depression in Women |
 CBC.ca |
Colonoscopy Lowers Rate of Cancer Deaths, Study Finds
New York Times A new study provides what independent researchers call the best evidence yet that colonoscopy — perhaps the most unloved cancer screening test — prevents deaths. Although many people have assumed colonoscopy must save lives because it is so often … Many Cancer Deaths Prevented by Colonoscopy Removing Polyps Cuts Colon Cancer Deaths by Half, Study Finds |
 MSF UK |
Myanmar : Big Issues With HIV & TB
Medical News Today Médecins Sans Frontières (MSF), the largest provider of HIV treatment in Myanmar, released a report today highlighting the urgency of treating HIV and multi-drug resistant Tuberculosis (MDR-TB) in their country – Myanmar used to be called Burma. Burma 'needs more funds to fight Aids' Doctors say 85000 in Myanmar desperate for HIV treatment, funding cuts … |
Related posts:
- Prescriptions: Medicare Panel Backs Prostate Drug – New York Times
- Federal Panel Split on Ban of Weight-Loss Drug – New York Times
- FDA advisory panel approves new drug for lupus, Benlysta – Los Angeles Times
- FDA Panel Rejects Expanded Use of Prostate Drug – New York Times
- FDA Panel Rejects Expanded Use of Prostate Drug – New York Times